For Novo Nordisk, Buzz Was A Mixed Blessing

As everyone knows, buzz works both ways. Some developments can generate desirable chatter and others yield some very unwanted yakking. Last month, Novo Nordisk certainly got its share of both, at leas…
Read the full story: Pharmalot